Hormonal IUDs, such as Mirena and Kyleena, release progestin, which can help manage heavy menstrual bleeding and reduce symptoms of conditions like endometriosis and adenomyosis. These women’s health medical devices provide a convenient and effective means of birth control, while addressing other reproductive health concerns.
More recently, OCON Therapeutics has been working on several uterus conforming IUDs which are a more natural, spherical shape, rather than T-shaped. The company places a strong emphasis on a patient-centred approach to women’s health, designing their IUDs to provide improved comfort, reduced side effects and increased user satisfaction. By focusing on the unique needs and experiences of women, OCON Therapeutics is a great example of a company aiming to enhance the overall IUD experience and improve access to reliable and effective contraception.